<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04283981</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-DB-19-1074</org_study_id>
    <nct_id>NCT04283981</nct_id>
  </id_info>
  <brief_title>Comparison of Operating Room Time Length With the Use of Virtual Surgical Planning Versus Conventional Treatment of Mandible Fractures</brief_title>
  <official_title>Comparison of Operating Room Time Length With the Use of Virtual Surgical Planning Versus Conventional Treatment of Mandible Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stryker Instruments</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to compare operating room time between conventional treatment
      techniques (without Virtual surgical Planning (VSP)) versus use of VSP and surgically-guided
      techniques and to compare and contrast the effect of any other variables that might have an
      effect on the overall result
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time taken to complete an open reduction internal fixation (ORIF)</measure>
    <time_frame>End of dissection until final screws are placed,about 2-3 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with malocclusion</measure>
    <time_frame>1 week post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with malocclusion</measure>
    <time_frame>3 weeks post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with malocclusion</measure>
    <time_frame>6 weeks post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with fractures that are not well aligned</measure>
    <time_frame>1 week post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with fractures that are not well aligned</measure>
    <time_frame>3 weeks post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with fractures that are not well aligned</measure>
    <time_frame>6 weeks post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with infections</measure>
    <time_frame>1 week post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with infections</measure>
    <time_frame>3 weeks post surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with infections</measure>
    <time_frame>6 weeks post surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Mandibular Fractures</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control group without use of VSP</intervention_name>
    <description>The control group will include patients that undergo mandibular reconstruction via open reduction internal fixation (intraoral or extraoral approach) in standard fashion (without virtual surgical planning assistance and occlusal splint)</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Treatment Group with use of VSP</intervention_name>
    <description>The treatment group corresponds to patients undergoing mandibular reconstruction via open reduction internal fixation (intraoral or extraoral approach) utilizing virtual surgical planning via 3D Systems, bite registration and fabrication of occlusal splint via intraoral digital scanner, and mandibular hardware</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient consent

          -  Complex mandible fracture (at least two fractures) that require ORIF of at least one
             fracture. This will exclude condylar fractures

        Exclusion Criteria:

          -  Patient refusal to participate in study

          -  Infected mandible fracture

          -  Closed reduction treatment of mandible fracture

          -  Fractures older than 2-3 weeks at the time of treatment

          -  Other concomitant mid-facial bone fractures (ie, zygomaticomaxillary complex (ZMC),
             Lefort fractures)

          -  Other etiologies than trauma of the mandibular fracture or pathologic fracture
             secondary to benign or malignant pathology that may require resection

          -  Pregnant patients will NOT be excluded from the study

          -  Co-morbidities (auto-immune disease, osteoporosis, titanium or metal allergy,
             uncontrolled diabetes (A1c greater than 8)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Woernley, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Timothy Woernley, DDS</last_name>
    <phone>(713) 486-4310</phone>
    <email>Timothy.C.Woernley@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nagi Demian</last_name>
    <phone>(713) 500-7833</phone>
    <email>Nagi.Demian@uth.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Timothy Woernley, DDS</last_name>
      <phone>713-486-4310</phone>
      <email>Timothy.C.Woernley@uth.tmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nagi Demian</last_name>
      <phone>(713) 500-7833</phone>
      <email>Nagi.Demian@uth.tmc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 19, 2020</study_first_submitted>
  <study_first_submitted_qc>February 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2020</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Timothy C. Woernley III</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mandibular Fractures</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

